Suppr超能文献

加纳自身免疫性风湿病患者 COVID-19 感染的管理及相关结局。

Management and associated outcomes of COVID-19 infection among Ghanaian autoimmune rheumatic disease patients.

机构信息

Department of Medicine and Therapeutics, University of Ghana Medical School, Legon, Accra, Ghana.

Rheumatology Unit, Department of Medicine and Therapeutics, Korle-Bu Teaching Hospital, Accra, Ghana.

出版信息

Ghana Med J. 2024 Sep;58(3):184-191. doi: 10.4314/gmj.v58i3.2.

Abstract

OBJECTIVE

This study assessed the prevalence of infection, management strategies and associated disease outcomes of COVID-19 among Autoimmune Rheumatic Disease (AIRD) patients in a teaching hospital in Ghana.

DESIGN

This was a retrospective cross-sectional study.

SETTING

Rheumatology Unit, Korle Bu Teaching Hospital.

PARTICIPANTS

Autoimmune Rheumatic Disease patients.

RESULTS

Thirty-one (31) out of approximately 1700 AIRD patients in the unit tested positive for COVID-19, registering a COVID-19 prevalence of 1.82%. The majority, 25(80.6%), were females with a mean ± SD age of 41.7 ± 12.8 years. Systemic lupus erythematosus was the most affected autoimmune rheumatic condition, reporting fever as the commonest COVID-19-related symptom. Most participants, 22(71%), were managed by the "self-isolation"/home management" strategy. In comparison, 7(22.5%) were monitored at the hospital, with both strategies having resulted in complete recovery. The remaining 2(6.5%) patients who managed under "intensive care unit" strategy resulted in mortality.

CONCLUSION

These findings highlight the relatively low frequency of COVID-19 infection among AIRD patients, the encouraging recovery, and the low severe disease rates observed within this cohort. Additionally, the outcome of self-isolation and home management strategies underscore the importance of personalised approaches to COVID-19 management in this population.

FUNDING

.

摘要

目的

本研究评估了加纳一家教学医院的自身免疫性风湿病 (AIRD) 患者中 COVID-19 的感染率、管理策略和相关疾病结局。

设计

这是一项回顾性的横断面研究。

地点

科勒布教学医院风湿病科。

参与者

自身免疫性风湿病患者。

结果

在该科室的大约 1700 名 AIRD 患者中,有 31 名(31%)检测出 COVID-19 阳性,COVID-19 的患病率为 1.82%。大多数患者(25 名,80.6%)为女性,平均年龄±标准差为 41.7±12.8 岁。系统性红斑狼疮是受影响最严重的自身免疫性疾病,报告发热是最常见的 COVID-19 相关症状。大多数患者(22 名,71%)采用“自我隔离/家庭管理”策略进行治疗。相比之下,7 名(22.5%)在医院接受监测,这两种策略都导致了完全康复。在接受“重症监护病房”策略治疗的其余 2 名(6.5%)患者中,出现了死亡。

结论

这些发现强调了 AIRD 患者 COVID-19 感染率相对较低,观察到该队列中恢复情况良好且严重疾病发生率较低。此外,自我隔离和家庭管理策略的结果突显了在该人群中针对 COVID-19 管理采取个体化方法的重要性。

资金

无。

相似文献

2
Evolution of COVID-19 in patients with autoimmune rheumatic diseases.
Aging (Albany NY). 2020 Dec 3;12(23):23427-23435. doi: 10.18632/aging.202193.
3
Study of familial aggregation of autoimmune rheumatic diseases in Asian Indian patients with systemic lupus erythematosus.
Rheumatol Int. 2019 Dec;39(12):2053-2060. doi: 10.1007/s00296-019-04355-z. Epub 2019 Jul 1.
4
Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Ann Rheum Dis. 2020 Nov;79(11):1393-1399. doi: 10.1136/annrheumdis-2020-217984. Epub 2020 Aug 7.
6
COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.
J Med Life. 2023 Jun;16(6):873-882. doi: 10.25122/jml-2023-0037.
7
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Clin Rheumatol. 2020 Nov;39(11):3195-3204. doi: 10.1007/s10067-020-05334-7. Epub 2020 Aug 27.
8
Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
Clin Rheumatol. 2023 Oct;42(10):2677-2690. doi: 10.1007/s10067-022-06486-4. Epub 2023 Jan 11.
9
Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.
Clin Rheumatol. 2021 Nov;40(11):4665-4670. doi: 10.1007/s10067-021-05801-9. Epub 2021 Jun 22.
10
COVID-19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic.
Intern Med J. 2024 Aug;54(8):1376-1383. doi: 10.1111/imj.16406. Epub 2024 May 30.

本文引用的文献

2
Transmission Dynamics of COVID-19 in Ghana and the Impact of Public Health Interventions.
Am J Trop Med Hyg. 2022 May 23;107(1):175-9. doi: 10.4269/ajtmh.21-0718.
3
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations.
Nat Rev Rheumatol. 2022 Apr;18(4):191-204. doi: 10.1038/s41584-022-00755-x. Epub 2022 Feb 25.
4
Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China.
Clin Rheumatol. 2022 Jun;41(6):1899-1910. doi: 10.1007/s10067-022-06086-2. Epub 2022 Feb 16.
7
Epidemiology of COVID-19 outbreak in Ghana, 2020.
Ghana Med J. 2020 Dec;54(4 Suppl):5-15. doi: 10.4314/gmj.v54i4s.3.
9
Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety.
Lupus Sci Med. 2021 Apr;8(1). doi: 10.1136/lupus-2021-000496.
10
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic.
Expert Rev Clin Immunol. 2021 Jun;17(6):561-571. doi: 10.1080/1744666X.2021.1908887. Epub 2021 Apr 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验